Projects

Multiple Expansion Plans For Bangladesh's Pharmaceutical Industry

The three leading pharmaceutical companies of Bangladesh, Acme Laboratories, Square Pharmaceuticals and Advanced Chemical Industries have taken up major expansion plans at Dhamrai, Kaliakoi and Narayanganj. Another pharmaceutical company, Eskayef Bangladesh Ltd. completed work on its new plant in August 2008. Acme Laboratories' new construction started in 2008 and will be ready by June 2010. Square Pharmaceuticals has started expanding this year and the project will be completed by 2016. Among other industry players, Beximco, Eskayef, Incepta, Opsonin, Renata, Aristopharma and Drug International some of them are laying out plans to increase their production capacities.

Piramal to establish first private opium processing company

The Mumbai-based Piramal Healthcare plans to set up a manufacturing unit to process raw opium for pharmaceutical use. It helps domestic pharma companies in locally procuring opium-based products like morphine, codeine and thebaine. Indian opium contains a range of chemical compounds such as morphine, codeine, thebaine, noscapine and papaverine, which have widespread medical and scientific uses. In making cough syrups, Codeine is one of the most sought opium products by the Indian pharmaceutical industry.

Microbix to build vaccine manufacturing plant in China

Microbix announced the completion of an agreement with the Chinese government for the construction of a new influenza vaccine manufacturing facility in the country.

Genzyme’s new R&D centre in China

Genzyme Corporation has announced the plan to construct a major new Research & Development centre in Beijing, China.

Beike Biotech to open Jiangsu stem cell storage facility in China

Jiangsu Stem Cell Storage and processing facility is to be constructed in Jiangsu province, China.

Unigene to set up pharmaceutical facility in china

Unigene plans to build pharmaceutical manufacturing plant and R&D centres in China.

Millipore plans new facility in Singapore

Millipore Corporation has announced the plans o open a new state-of -the-art applications and training facility in Singapore.

Alcon plans pharmaceutical manufacturing plant in Singapore

Alcon plans to build a manufacturing facility in Singapore for the production of pharmaceuticals and their distribution across major parts of Asia.

Teva to set up API facility in India

Teva is planning to set up an Active Pharmaceutical Ingredient in the country. The project is aimed to be achieved in the next two years.

PTR to build stem cell manufacturing plant in Malayasia

Pahang Technology Resources is teaming up with BCRO Stem Cell Xenotransplantation to jointly build a stem cell manufacturing plant in Malayasia.

Genentech sets up manufacturing plant in Singapore

Genentech is setting up a microbial- based biologics manufacturing plant in Singapore with an investment of approximately US$ 140 million by 2010. It is intended to manufacture LUCENTIS® for curing wet age-related macular degeneration.

Aptuit Laurus's new manufacturing facility in India

Aptuit, Inc. and Laurus Labs Limited have formed a joint venture to offer manufacturing facilities in Vishakhapatnam. The initial phase of the manufacturing plant is expected to complete by early 2008.

New R&D Center in Madhya Pradesh, India

The Government of Madhya Pradesh proposes to establish an integrated R&D center in the State. The center will offer specialty services in drug discovery.

Janssen-Cilag and Johnson & Johnson to open new facility in Mumbai

Janssen-Cilag and Johnson & Johnson Pharmaceutical Research & Development (J&JPRD) broke ground for a future pharmaceutical research building after opening the extended and renovated Analytical & Pharmaceutical Development Center (APDC) in Mumbai.

Klöckner Pentaplast to build manufacturing plant in India

The Klöckner Pentaplast Group (kp) a leading producer and supplier of films for pharmaceutical, medical device, and general-purpose thermoform packaging announced its plans to build a manufacturing plant in India in Aurangabad.

Dragon to build new nanotechnology packaging plant

Dragon International Group Corp plans to build a new manufacturing facility which will be utilised to make new packaging products developed through the use of nanotechnologies.

Zydus and Mayne builds new plant to manufacture oncology products in India

Zydus Cadila and Mayne Pharma to set up a 50:50 joint venture company to manufacture generic injectable, cytotoxic (anti-cancer) medicines and active pharmaceutical ingredients (API) for global markets.

Dishman Pharma manufacturing facility in Shanghai

Dishman Pharmaceuticals and Chemicals Ltd is setting up a new greenfield manufacturing facility in Shanghai Chemical Industry Park at a cost of Rs 45 crore ($10 million). The project is expected to go on stream by the end of 2007.

Novartis’s new strategic biomedical R&D center in Shanghai

Novartis announced plans to build an integrated biomedical Research & Development center in Shanghai's Zhangjiang Hi-Tech Park. Initial investment of USD 100 million to create Shanghai site, set to begin operations in May 2007.

GSK’s New R&D Plant in Singapore

GlaxoSmithKline (GSK) is investing US$ 115 million in a new R&D pilot plant at its Global Manufacturing Supply (GMS) site in Jurong, Singapore.

Lonza Group and Bio*One’s Custom Biopharmaceuticals Plant, Singapore

In a joint venture, Lonza Group, a Swiss chemical and biotechnology company, and Singapore’s Bio*One Capital, biomedical sciences investment management company, are developing mammalian cell culture plant in Singapore. The project is scheduled for completion by the end of 2009 with an estimated investment of US$ 250 million.

SCHOTT's Pharmaceutical Packaging Plant, China

SCHOTT has become the first international manufacturer of primary pharmaceutical packaging made of glass to establish a production site in China.

Inno Biologics' cGMP Biopharmaceutical Manufacturing Plant

Inno Biologics, a Malaysian government-backed company, is in the process of assembling the country’s first cGMP modular biopharmaceutical production plant that was shipped from Pharmaplan International, Germany.

Novo Nordisk Expands Production Plant, China

Novo Nordisk, the Denmark-based healthcare and diabetic care company is building its new assembling and production facility in Tianjing, the company’s production base in China.